Skip to main content

. 1984 Jan 28;288(6413):283–284. doi: 10.1136/bmj.288.6413.283-a

Effect of digoxin and vitamin E in preventing cardiac damage caused by doxorubicin in acute myeloid leukaemia.

J A Whittaker, S A Al-Ismail

PMCID: PMC1444076 PMID: 6419896

283

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Al-Ismail S., Whittaker J. A. Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia. Br Med J. 1979 May 26;1(6175):1392–1395. doi: 10.1136/bmj.1.6175.1392. [DOI] [PMC free article] [PubMed] [Google Scholar]
Myers C. E., McGuire W., Young R. Adriamycin: amelioration of toxicity by alpha-tocopherol. Cancer Treat Rep. 1976 Jul;60(7):961–962. [PubMed] [Google Scholar]
Von Hoff D. D., Layard M. W., Basa P., Davis H. L., Jr, Von Hoff A. L., Rozencweig M., Muggia F. M. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979 Nov;91(5):710–717. doi: 10.7326/0003-4819-91-5-710. [DOI] [PubMed] [Google Scholar]
Weissler A. M., Harris W. S., Schoenfeld C. D. Bedside technics for the evaluation of ventricular function in man. Am J Cardiol. 1969 Apr;23(4):577–583. doi: 10.1016/0002-9149(69)90012-5. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES